279 related articles for article (PubMed ID: 10532593)
1. The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia.
Wilson PD; Geng L; Li X; Burrow CR
Lab Invest; 1999 Oct; 79(10):1311-23. PubMed ID: 10532593
[TBL] [Abstract][Full Text] [Related]
2. Identification of phosphorylation sites in the PKD1-encoded protein C-terminal domain.
Li HP; Geng L; Burrow CR; Wilson PD
Biochem Biophys Res Commun; 1999 Jun; 259(2):356-63. PubMed ID: 10362514
[TBL] [Abstract][Full Text] [Related]
3. Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney.
van Adelsberg J
Dev Genet; 1999; 24(3-4):299-308. PubMed ID: 10322638
[TBL] [Abstract][Full Text] [Related]
4. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).
Veldhuisen B; Spruit L; Dauwerse HG; Breuning MH; Peters DJ
Eur J Hum Genet; 1999 Dec; 7(8):860-72. PubMed ID: 10602361
[TBL] [Abstract][Full Text] [Related]
5. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.
Hanaoka K; Qian F; Boletta A; Bhunia AK; Piontek K; Tsiokas L; Sukhatme VP; Guggino WB; Germino GG
Nature; 2000 Dec 21-28; 408(6815):990-4. PubMed ID: 11140688
[TBL] [Abstract][Full Text] [Related]
6. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation.
Geng L; Burrow CR; Li HP; Wilson PD
Biochim Biophys Acta; 2000 Dec; 1535(1):21-35. PubMed ID: 11113628
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
Sessa A; Ghiggeri GM; Turco AE
J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
[TBL] [Abstract][Full Text] [Related]
8. Disruption of polycystin-1 function interferes with branching morphogenesis of the ureteric bud in developing mouse kidneys.
Polgar K; Burrow CR; Hyink DP; Fernandez H; Thornton K; Li X; Gusella GL; Wilson PD
Dev Biol; 2005 Oct; 286(1):16-30. PubMed ID: 16122726
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
10. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
[TBL] [Abstract][Full Text] [Related]
11. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
[TBL] [Abstract][Full Text] [Related]
12. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.
Lu W; Peissel B; Babakhanlou H; Pavlova A; Geng L; Fan X; Larson C; Brent G; Zhou J
Nat Genet; 1997 Oct; 17(2):179-81. PubMed ID: 9326937
[TBL] [Abstract][Full Text] [Related]
13. K562 erythroid and HL60 macrophage differentiation downregulates polycystin, a large membrane-associated protein.
Aguiari G; Piva R; Manzati E; Mazzoni E; Augello G; Chiari E; Moretti S; Neri LM; del Senno L
Exp Cell Res; 1998 Oct; 244(1):259-67. PubMed ID: 9770368
[TBL] [Abstract][Full Text] [Related]
14. Depletion of PKD1 by an antisense oligodeoxynucleotide induces premature G1/S-phase transition.
Kim H; Bae Y; Jeong W; Ahn C; Kang S
Eur J Hum Genet; 2004 Jun; 12(6):433-40. PubMed ID: 15054393
[TBL] [Abstract][Full Text] [Related]
15. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.
Nauli SM; Rossetti S; Kolb RJ; Alenghat FJ; Consugar MB; Harris PC; Ingber DE; Loghman-Adham M; Zhou J
J Am Soc Nephrol; 2006 Apr; 17(4):1015-25. PubMed ID: 16565258
[TBL] [Abstract][Full Text] [Related]
16. Cation channel regulation by COOH-terminal cytoplasmic tail of polycystin-1: mutational and functional analysis.
Vandorpe DH; Wilhelm S; Jiang L; Ibraghimov-Beskrovnaya O; Chernova MN; Stuart-Tilley AK; Alper SL
Physiol Genomics; 2002 Feb; 8(2):87-98. PubMed ID: 11875186
[TBL] [Abstract][Full Text] [Related]
17. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of cystic kidney diseases].
Walz G
Verh Dtsch Ges Pathol; 2002; 86():138-44. PubMed ID: 12647363
[TBL] [Abstract][Full Text] [Related]
19. In vitro cystogenesis: the search for drugs antagonizing cyst development.
Ibraghimov-Beskrovnaya O; Bukanov NO
Nephrol Ther; 2006 Jan; 2 Suppl 2():S109-14. PubMed ID: 17373209
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane domain analysis of polycystin-1, the product of the polycystic kidney disease-1 (PKD1) gene: evidence for 11 membrane-spanning domains.
Nims N; Vassmer D; Maser RL
Biochemistry; 2003 Nov; 42(44):13035-48. PubMed ID: 14596619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]